REVIEW ON COCRYSTAL AS AN APPROACH WITH NEWER IMPLICATIONS IN PHARMACEUTICAL FIELD

Cocrystal is a crystalline structure consisting of two or more components that form a unique structure having specific properties. The physical and chemical property improvements through pharmaceutical co-crystals draw closer the fields of crystal engineering and pharmaceutical sciences. A pharmaceutical co-crystal is a single crystalline solid that incorporates two neutral molecules, one being an active pharmaceutical ingredient (API) and the other a co-crystal former. This technology is used to identify and develop new proprietary forms of widely prescribed drugs and offer a chance to increase the number of forms of an API. This review focuses on properties of cocrystals, their methods of synthesis and applications in the field of pharmacy.

[1]  J. Bernstein,et al.  An Alternate Crystal Form of Gabapentin: A Cocrystal with Oxalic Acid , 2008 .

[2]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[3]  S. Callear.  Preparation, characterisation and structural analysis of salts and co-crystals of organic compounds , 2008 .

[4]  M. C. Etter.  Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .

[5]  Claus Cornett,et al.  Near-infrared spectroscopy for cocrystal screening. A comparative study with Raman spectroscopy. , 2008, Analytical chemistry.

[6]  Raj Suryanarayanan,et al.  A rapid thermal method for cocrystal screening , 2008 .

[7]  E. Tiekink,et al.  What is a co-crystal? , 2008 .

[8]  Michael J Zaworotko,et al.  Expanding the scope of crystal form evaluation in pharmaceutical science. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[9]  L. Reddy,et al.  Polymorphs and polymorphic cocrystals of temozolomide. , 2008, Chemistry, an Asian journal.

[10]  Kenneth I. Hardcastle,et al.  Cocrystals of Piroxicam with Carboxylic Acids , 2007 .

[11]  William Jones,et al.  Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement , 2006 .

[12]  S. Rohani,et al.  Preparation and Characterization of Theophylline-Nicotinamide Cocrystal , 2009 .

[13]  R. Davey,et al.  On the solubility of saccharinate salts and cocrystals , 2008 .

[14]  G. P. Stahly.  Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals , 2007 .

[15]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[16]  M. Caira,et al.  Selective formation of hydrogen bonded cocrystals between a sulfonamide and aromatic carboxylic acids in the solid state , 1995 .

[17]  P. W. Cains,et al.  Discovering New Co-Crystals , 2009 .

[18]  Orn Almarsson,et al.  Performance comparison of a co-crystal of carbamazepine with marketed product. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Christer B Aakeröy,et al.  Cocrystal or salt: does it really matter? , 2007, Molecular pharmaceutics.

[20]  A. P. Lötter,et al.  Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. , 1987, Journal of pharmaceutical sciences.

[21]  P. W. Cains,et al.  Co-Crystal Polymorphs from a Solvent-Mediated Transformation , 2008 .

[22]  K. Fujii,et al.  COCRYSTALLINE PHASE TRANSFORMATION OF BINARY MIXTURE OF TRIMETHOPRIM AND SULFAMETHOXAZOLE BY SLURRY TECHNIQUE , 2010 .

[23]  J. Donohue.  The Hydrogen Bond in Organic Crystals , 1952 .

[24]  V. Lynch,et al.  Molecular Complexes of Homologous Alkanedicarboxylic Acids with Isonicotinamide: X-ray Crystal Structures, Hydrogen Bond Synthons, and Melting Point Alternation , 2003 .

[25]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[26]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[27]  J. Keith Guillory,et al.  Handbook of Pharmaceutical Salts: Properties, Selection, and Use Edited by P. Heinrich Stahl and Camile G. Wermuth. VHCA, Verlag Helvetica Chimica Acta, Zürich, Switzerland, and Wiley-VCH, Weinheim, Germany. 2002. vix + 374 pp. 17.5 × 24.5 cm. ISBN 3-906390-26-8. $130.00 , 2003 .

[28]  Peddy Vishweshwar,et al.  Supramolecular synthon polymorphism in 2 : 1 co-crystal of 4-hydroxybenzoic acid and 2,3,5,6-tetramethylpyrazine. , 2007, Chemical communications.

[29]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[30]  S. Reutzel,et al.  Hydrogen Bond Directed Cocrystallization and Molecular Recognition Properties of Acyclic Imides , 1991 .

[31]  J. McMahon,et al.  Crystal Engineering of Pharmaceutical Co‐crystals , 2006 .

[32]  G. P. Stahly,et al.  A Survey of Cocrystals Reported Prior to 2000 , 2009 .

[33]  B. Spong.  Enhancing the pharmaceutical behavior of poorly soluble drugs through the formation of cocrystals and mesophases. , 2005 .

[34]  Sarah J. Nehm,et al.  Cocrystals: Design, Properties and Formation Mechanisms , 2013 .

[35]  A. Matzger,et al.  Polymorphism in Carbamazepine Cocrystals. , 2008, Crystal growth & design.

[36]  Narayan Variankaval,et al.  Preparation and Solid-State Characterization of Nonstoichiometric Cocrystals of a Phosphodiesterase-IV Inhibitor and l-Tartaric Acid , 2006 .

[37]  R. Tan,et al.  Dimorphs of a 1 : 1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph , 2009 .

[38]  Sarah J. Nehm,et al.  Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation , 2006 .

[39]  Andrew V. Trask,et al.  An overview of pharmaceutical cocrystals as intellectual property. , 2007, Molecular pharmaceutics.

[40]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[41]  A. Newman,et al.  Pharmaceutical Cocrystals and Their Physicochemical Properties , 2009, Crystal growth & design.

[42]  S. Velaga,et al.  Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization , 2008, Pharmaceutical Research.

[43]  Naír Rodríguez-Hornedo,et al.  Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase , 2006, Pharmaceutical Research.

[44]  Jagadese J. Vittal,et al.  Frontiers in crystal engineering , 2006 .